Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma

Multiple myeloma (MM) patients frequently attain a bone marrow (BM) minimal residual disease (MRD) negativity status in response to treatment. We identified 568 patients who achieved BM MRD negativity following autologous stem cell transplantation (ASCT) and maintenance combination therapy with an i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohan, Meera, Kendrick, Samantha, Szabo, Aniko, Yarlagadda, Naveen, Atwal, Dinesh, Pandey, Yadav, Roy, Arya, Parikh, Richa, Lopez, James, Thanendrarajan, Sharmilan, Schinke, Carolina, Alapat, Daisy, Sawyer, Jeffrey, Tian, Erming, Tricot, Guido, van Rhee, Frits, Zangari, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Myeloid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945288/
https://www.ncbi.nlm.nih.gov/pubmed/34807986
http://dx.doi.org/10.1182/bloodadvances.2021005822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945288/
https://www.ncbi.nlm.nih.gov/pubmed/34807986
http://dx.doi.org/10.1182/bloodadvances.2021005822

Ejemplares similares